On the public citation graph

Prospects for a dengue virus vaccine

0 signed · 690 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →no DOI in the source recordopenalex-snapshot
Staphylococcal nasal carriage of health care workers.
inferredcites →https://doi.org/10.1002/(sici)1096-9071(200004)60:4<432::aid-jmv11>3.0.co;2-7openalex-snapshot
Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia
inferredcites →https://doi.org/10.1006/viro.1998.9200openalex-snapshot
Monoclonal Antibody Mapping of the Envelope Glycoprotein of the Dengue 2 Virus, Jamaica
inferredcites →https://doi.org/10.1006/viro.2002.1462openalex-snapshot
Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates
inferredcites →https://doi.org/10.1007/bf02015615openalex-snapshot
Ultrasound findings in dengue haemorrhagic fever
inferredcites →https://doi.org/10.1007/s10620-005-2722-6openalex-snapshot
Dengue Hemorrhagic Fever and Fulminant Hepatic Failure
inferredcites →https://doi.org/10.1016/b978-0-443-06668-9.50077-6openalex-snapshot
Dengue and Dengue Hemorrhagic Fever
inferredcites →https://doi.org/10.1016/j.jcv.2006.04.010openalex-snapshot
Antibodies from patients with dengue viral infection mediate cellular cytotoxicity
inferredcites →https://doi.org/10.1016/j.vaccine.2005.03.042openalex-snapshot
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
inferredcites →https://doi.org/10.1016/j.vaccine.2005.09.029openalex-snapshot
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults☆
inferredcites →https://doi.org/10.1016/j.vaccine.2006.03.066openalex-snapshot
Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)
inferredcites →https://doi.org/10.1016/s0031-3025(16)34854-1openalex-snapshot
Dengue haemorrhagic fever: diagnosis, treatment, prevention and control
inferredcites →https://doi.org/10.1016/s0042-6822(03)00542-7openalex-snapshot
Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys
inferredcites →https://doi.org/10.1016/s0065-3527(03)60011-4openalex-snapshot
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
inferredcites →https://doi.org/10.1016/s0065-3527(03)61006-7openalex-snapshot
Dengue Epidemiology: Virus Epidemiology, Ecology, And Emergence
inferredcites →https://doi.org/10.1016/s0065-3527(08)60342-5openalex-snapshot
Impact of Dengue/Dengue Hemorrhagic Fever on The Developing World
inferredcites →https://doi.org/10.1016/s0092-8674(02)00660-8openalex-snapshot
Structure of Dengue Virus
inferredcites →https://doi.org/10.1016/s0140-6736(06)69006-5openalex-snapshot
The WHO dengue classification and case definitions: time for a reassessment
inferredcites →https://doi.org/10.1016/s0264-410x(01)00020-2openalex-snapshot
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
inferredcites →https://doi.org/10.1016/s0264-410x(03)00488-2openalex-snapshot
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys
inferredcites →https://doi.org/10.1034/j.1399-0039.2002.600405.xopenalex-snapshot
HLA‐A and ‐B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais
inferredcites →https://doi.org/10.1038/ng1550openalex-snapshot
A variant in the CD209 promoter is associated with severity of dengue disease
inferredcites →https://doi.org/10.1038/nm1144openalex-snapshot
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
inferredcites →https://doi.org/10.1038/nm887openalex-snapshot
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
inferredcites →https://doi.org/10.1038/nrmicro1067openalex-snapshot
A structural perspective of the flavivirus life cycle
inferredcites →https://doi.org/10.1084/jem.170.3.763openalex-snapshot
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity.
inferredcites →https://doi.org/10.1086/315215openalex-snapshot
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
inferredcites →https://doi.org/10.1086/380762openalex-snapshot
Dengue Hemorrhagic Fever in Infants: A Study of Clinical and Cytokine Profiles
inferredcites →https://doi.org/10.1086/383043openalex-snapshot
Localization of Dengue Virus in Naturally Infected Human Tissues, by Immunohistochemistry and In Situ Hybridization
inferredcites →https://doi.org/10.1086/427780openalex-snapshot
rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers
inferredcites →https://doi.org/10.1086/431520openalex-snapshot
Dengue Virus (DV) Enhancing Antibody Activity in Preillness Plasma Does Not Predict Subsequent Disease Severity or Viremia in Secondary DV Infection
inferredcites →https://doi.org/10.1086/500949openalex-snapshot
Vascular Leakage in Severe Dengue Virus Infections: A Potential Role for the Nonstructural Viral Protein NS1 and Complement
inferredcites →https://doi.org/10.1086/503372openalex-snapshot
Protection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus Vaccination
inferredcites →https://doi.org/10.1086/508492openalex-snapshot
Dengue Virus Infections in the First 2 Years of Life and the Kinetics of Transplacentally Transferred Dengue Neutralizing Antibodies in Thai Children
inferredcites →https://doi.org/10.1086/514047openalex-snapshot
Early Clinical and Laboratory Indicators of Acute Dengue Illness
inferredcites →https://doi.org/10.1089/vim.2006.19.10openalex-snapshot
Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics
inferredcites →https://doi.org/10.1093/aje/152.9.793openalex-snapshot
Epidemiologic Studies on Dengue in Santiago de Cuba, 1997
inferredcites →https://doi.org/10.1093/aje/kwf005openalex-snapshot
Epidemiology of Inapparent and Symptomatic Acute Dengue Virus Infection: A Prospective Study of Primary School Children in Kamphaeng Phet, Thailand
inferredcites →https://doi.org/10.1093/infdis/174.6.1176openalex-snapshot
Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys
inferredcites →https://doi.org/10.1097/01.inf.0000109289.55856.27openalex-snapshot
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
inferredcites →https://doi.org/10.1097/01.qco.0000244047.31135.faopenalex-snapshot
Immunopathological mechanisms in dengue and dengue hemorrhagic fever
inferredcites →https://doi.org/10.1099/vir.0.81256-0openalex-snapshot
Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge
inferredcites →https://doi.org/10.1111/j.1365-3156.2004.01295.xopenalex-snapshot
Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand
inferredcites →https://doi.org/10.1111/j.1399-0039.2004.00304.xopenalex-snapshot
TNF‐α‐308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients
inferredcites →https://doi.org/10.1126/science.3277268openalex-snapshot
Pathogenesis of Dengue: Challenges to Molecular Biology
inferredcites →https://doi.org/10.1128/cmr.11.3.480openalex-snapshot
Dengue and Dengue Hemorrhagic Fever
inferredcites →https://doi.org/10.1128/jvi.00284-06openalex-snapshot
Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques
inferredcites →https://doi.org/10.1128/jvi.01122-06openalex-snapshot
Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion
inferredcites →https://doi.org/10.1128/jvi.60.3.1153-1155.1986openalex-snapshot
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1
inferredcites →https://doi.org/10.1128/jvi.63.12.5086-5091.1989openalex-snapshot
Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes
inferredcites →https://doi.org/10.1128/jvi.63.6.2853-2856.1989openalex-snapshot
Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis
inferredcites →https://doi.org/10.1128/jvi.64.9.4356-4363.1990openalex-snapshot
Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis
inferredcites →https://doi.org/10.1128/jvi.70.6.3930-3937.1996openalex-snapshot
Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys
inferredcites →https://doi.org/10.1128/jvi.74.7.3011-3019.2000openalex-snapshot
Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the 5′ Noncoding Region and Nonstructural Proteins 1 and 3
inferredcites →https://doi.org/10.1128/jvi.75.16.7290-7304.2001openalex-snapshot
Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine
inferredcites →https://doi.org/10.1128/jvi.75.16.7769-7773.2001openalex-snapshot
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
inferredcites →https://doi.org/10.1128/jvi.77.2.1653-1657.2003openalex-snapshot
A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys
inferredcites →https://doi.org/10.1128/jvi.77.21.11436-11447.2003openalex-snapshot
Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development
inferredcites →https://doi.org/10.1128/jvi.79.13.8004-8013.2005openalex-snapshot
Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses
inferredcites →https://doi.org/10.1128/jvi.79.9.5516-5528.2005openalex-snapshot
Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys
inferredcites →https://doi.org/10.1128/jvi.80.5.2170-2182.2006openalex-snapshot
RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral Replication
inferredcites →https://doi.org/10.1186/1471-2334-4-39openalex-snapshot
Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2
inferredcites →https://doi.org/10.1259/bjr/54704044openalex-snapshot
Role of ultrasound in dengue fever
inferredcites →https://doi.org/10.1590/s1413-86702004000200006openalex-snapshot
Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases
inferredcites →https://doi.org/10.3201/eid0812.020170openalex-snapshot
Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored
inferredcites →https://doi.org/10.3201/eid0903.020219openalex-snapshot
Amplification of the Sylvatic Cycle of Dengue Virus Type 2, Senegal, 1999–2000: Entomologic Findings and Epidemiologic Considerations
inferredcites →https://doi.org/10.3201/eid1105.041063openalex-snapshot
Dengue Fever, Hawaii, 2001–2002
inferredcites →https://doi.org/10.4049/jimmunol.99.2.285openalex-snapshot
A Plaque Reduction Test for Dengue Virus Neutralizing Antibodies
inferredcites →https://doi.org/10.4161/hv.2.2.2555openalex-snapshot
Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All
inferredcites →https://doi.org/10.4161/hv.2.4.2944openalex-snapshot
The Live Attenuated Dengue Serotype 1 Vaccine rDEN1Δ30 is Safe and Highly Immunogenic in Healthy Adult Volunteers
inferredcites →https://doi.org/10.4161/hv.2.6.3494openalex-snapshot
rDEN2/4Δ30(ME), a Live Attenuated Chimeric Dengue Serotype 2 Vaccine, is Safe and Highly Immunogenic in Healthy Dengue-Naïve Adults
inferredcites →https://doi.org/10.4269/ajtmh.1952.1.30openalex-snapshot
Research on Dengue during World War II
inferredcites →https://doi.org/10.4269/ajtmh.1969.18.972openalex-snapshot
Dengue and Chikungunya Virus Infection in Man in Thailand, 1962–1964
inferredcites →https://doi.org/10.4269/ajtmh.1969.18.997openalex-snapshot
Dengue and Chikungunya Virus Infection in Man in Thailand, 1962–1964
inferredcites →https://doi.org/10.4269/ajtmh.1973.22.237openalex-snapshot
An epidemic of dengue on Tahiti associated with hemorrhagic manifestations
inferredcites →https://doi.org/10.4269/ajtmh.1974.23.974openalex-snapshot
Etiologies of the Experimental Dengues of Siler and Simmons
inferredcites →https://doi.org/10.4269/ajtmh.1978.27.581openalex-snapshot
Epidemiologic, Clinical, and Virologic Observations on Dengue in the Kingdom of Tonga
inferredcites →https://doi.org/10.4269/ajtmh.1979.28.701openalex-snapshot
Epidemic Dengue Hemorrhagic Fever in Rural Indonesia
inferredcites →https://doi.org/10.4269/ajtmh.1979.28.711openalex-snapshot
Epidemic Dengue Hemorrhagic Fever in Rural Indonesia
inferredcites →https://doi.org/10.4269/ajtmh.1981.30.1094openalex-snapshot
Epidemic Dengue 3 in Central Java, Associated with Low Viremia in Man
inferredcites →https://doi.org/10.4269/ajtmh.1987.36.427openalex-snapshot
Monoclonal Antibodies against Dengue 2 Virus E-Glycoprotein Protect Mice against Lethal Dengue Infection
inferredcites →https://doi.org/10.4269/ajtmh.1988.38.172openalex-snapshot
A Prospective Study of Dengue Infections in Bangkok
inferredcites →https://doi.org/10.4269/ajtmh.1988.38.411openalex-snapshot
Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants
inferredcites →https://doi.org/10.4269/ajtmh.1989.40.444openalex-snapshot
Antibody-Dependent Enhancement of Dengue Virus Growth in Human Monocytes as a Risk Factor for Dengue Hemorrhagic Fever
inferredcites →https://doi.org/10.4269/ajtmh.1989.41.576openalex-snapshot
Monoclonal Antibodies for Dengue Virus prM Glycoprotein Protect Mice against Lethal Dengue Infection
inferredcites →https://doi.org/10.4269/ajtmh.1990.42.179openalex-snapshot
Dengue Hemorrhagic Fever in Cuba, 1981: A Retrospective Seroepidemiologic Study
inferredcites →https://doi.org/10.4269/ajtmh.1992.47.265openalex-snapshot
Liver Biochemical Tests and Dengue Fever
inferredcites →https://doi.org/10.4269/ajtmh.1993.48.793openalex-snapshot
Unusual Neurologic Manifestations Occurring during Dengue Fever Infection
inferredcites →https://doi.org/10.4269/ajtmh.1996.55.504openalex-snapshot
Immunogenic and Protective Response in Mice Immunized with a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype Made in Fetal Rhesus Lung Cells
inferredcites →https://doi.org/10.4269/ajtmh.2001.64.310openalex-snapshot
Sylvatic transmission of arboviruses among Bornean orangutans.
inferredcites →https://doi.org/10.4269/ajtmh.2001.65.405openalex-snapshot
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
inferredcites →https://doi.org/10.4269/ajtmh.2001.65.414openalex-snapshot
A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.
inferredcites →https://doi.org/10.4269/ajtmh.2002.66.264openalex-snapshot
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
inferredcites →https://doi.org/10.4269/ajtmh.2003.69.129openalex-snapshot
INDUCTION OF NEUTRALIZING ANTIBODIES AND PARTIAL PROTECTION FROM VIRAL CHALLENGE IN MACACA FASCICULARIS IMMUNIZED WITH RECOMBINANT DENGUE 4 VIRUS ENVELOPE GLYCOPROTEIN EXPRESSED IN PICHIA PASTORIS
inferredcites →https://doi.org/10.4269/ajtmh.2003.69.48openalex-snapshot
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
inferredcites →https://doi.org/10.4269/ajtmh.2003.69.6_suppl.0690024openalex-snapshot
VACCINATION OF HUMAN VOLUNTEERS WITH MONOVALENT AND TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE CANDIDATES
inferredcites →https://doi.org/10.4269/ajtmh.2004.71.811openalex-snapshot
GENETICALLY MODIFIED, LIVE ATTENUATED DENGUE VIRUS TYPE 3 VACCINE CANDIDATES
inferredcites →https://doi.org/10.4269/ajtmh.2005.73.435openalex-snapshot
COMPARISON OF CLINICAL FEATURES AND HEMATOLOGIC ABNORMALITIES BETWEEN DENGUE FEVER AND DENGUE HEMORRHAGIC FEVER AMONG CHILDREN IN THE PHILIPPINES
inferredcites →https://doi.org/10.4269/ajtmh.2006.75.986openalex-snapshot
GROWTH CHARACTERISTICS OF CHIMERIVAX-DEN VACCINE VIRUSES IN AEDES AEGYPTI AND AEDES ALBOPICTUS FROM THAILAND

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.5281/zenodo.816339openalex-extracted
Vaccine Development Against Dengue, A Viral Disease Of Increasing Significance To Global Public Health
inferred← citeshttps://doi.org/10.1001/jama.2007.31-aopenalex-snapshot
Dengue and Hemorrhagic Fever
inferred← citeshttps://doi.org/10.1002/9780813809793.ch23openalex-snapshot
Experimental Infection of Nonhuman Primates with Viruses of Medical Importance
inferred← citeshttps://doi.org/10.1002/9781118148594.ch9openalex-snapshot
Dengue: A Water‐Borne Disease
inferred← citeshttps://doi.org/10.1002/adfm.202105059openalex-snapshot
Developing Acid‐Responsive Glyco‐Nanoplatform Based Vaccines for Enhanced Cytotoxic T‐lymphocyte Responses Against Cancer and SARS‐CoV‐2
inferred← citeshttps://doi.org/10.1002/adtp.201800079openalex-snapshot
Therapeutic Potential of Biomineralization‐Based Engineering
inferred← citeshttps://doi.org/10.1002/bab.70138openalex-snapshot
High‐Throughput Virtual Screening of Phytochemicals From Indian Medicinal Plants for the Identification of Potential Inhibitors Against NS2B‐NS3 Protease of Dengue Virus
inferred← citeshttps://doi.org/10.1002/chem.201705936openalex-snapshot
Biomineralization State of Viruses and Their Biological Potential
inferred← citeshttps://doi.org/10.1002/ddr.20455openalex-snapshot
Therapeutic opportunities in dengue infection
inferred← citeshttps://doi.org/10.1002/ebch.168openalex-snapshot
Three commentaries on ‘Corticosteroids for treating dengue shock syndrome’, with introduction by EBCH editor
inferred← citeshttps://doi.org/10.1002/jgm.3297openalex-snapshot
Antibody‐dependent enhancement (ADE) of dengue virus: Identification of the key amino acid that is vital in DENV vaccine research
inferred← citeshttps://doi.org/10.1002/jmv.21408openalex-snapshot
Primary human endothelial cells support direct but not antibody‐dependent enhancement of dengue viral infection
inferred← citeshttps://doi.org/10.1002/jmv.24167openalex-snapshot
Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1
inferred← citeshttps://doi.org/10.1002/jmv.24731openalex-snapshot
Zika virus: Global health challenge, threat and current situation
inferred← citeshttps://doi.org/10.1002/jmv.24883openalex-snapshot
An evaluation of asymptomatic Dengue infections among blood donors during the 2014 Dengue outbreak in Guangzhou, China
inferred← citeshttps://doi.org/10.1002/jmv.25561openalex-snapshot
Significance of RANTES‐CCR5 axis and linked downstream immunomodulation in Dengue pathogenesis: A study from Guwahati, India
inferred← citeshttps://doi.org/10.1002/jmv.29895openalex-snapshot
Pathogenicity and transcriptomic resolution in dengue virus serotype 1 infected AGB6 mouse model
inferred← citeshttps://doi.org/10.1007/978-1-4614-2182-5_7openalex-snapshot
Viral Genomics: Implications for the Understanding and Control of Emerging Viral Diseases
inferred← citeshttps://doi.org/10.1007/978-1-4614-3961-5_1openalex-snapshot
Predictive Dynamics: Modeling for Virological Surveillance and Clinical Management of Dengue
inferred← citeshttps://doi.org/10.1007/978-1-4614-4496-1_10openalex-snapshot
Dengue Infections
inferred← citeshttps://doi.org/10.1007/978-1-4939-0348-1_7openalex-snapshot
Cell-Based Flavivirus Infection (CFI) Assay for the Evaluation of Dengue Antiviral Candidates Using High-Content Imaging
inferred← citeshttps://doi.org/10.1007/978-1-4939-7237-1_1openalex-snapshot
The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses
inferred← citeshttps://doi.org/10.1007/978-1-62703-484-5_15openalex-snapshot
Cell-Based Antiviral Assays for Screening and Profiling Inhibitors Against Dengue Virus
inferred← citeshttps://doi.org/10.1007/978-1-62703-484-5_16openalex-snapshot
A Duplex Real-Time RT-PCR Assay for Profiling Inhibitors of Four Dengue Serotypes
inferred← citeshttps://doi.org/10.1007/978-1-62703-484-5_19openalex-snapshot
Expression and Purification of Dengue Virus NS5 Polymerase and Development of a High-Throughput Enzymatic Assay for Screening Inhibitors of Dengue Polymerase
inferred← citeshttps://doi.org/10.1007/978-3-032-25494-8_10openalex-snapshot
From Random Walks to Epidemic Spreading: A Compartment Model with Mortality for Vector-Transmitted Diseases
inferred← citeshttps://doi.org/10.1007/978-3-319-13884-8_7openalex-snapshot
Dengue
inferred← citeshttps://doi.org/10.1007/978-3-642-02215-9_10openalex-snapshot
Dengue Vaccine Candidates in Development
inferred← citeshttps://doi.org/10.1007/978-3-642-02215-9_11openalex-snapshot
Targeted Mutagenesis as a Rational Approach to Dengue Virus Vaccine Development
inferred← citeshttps://doi.org/10.1007/978-3-7643-8713-6_8openalex-snapshot
Dengue-Fieber und Dengue hämorrhagisches Fieber
inferred← citeshttps://doi.org/10.1007/s00005-018-0525-7openalex-snapshot
Role of Monocytes in the Pathogenesis of Dengue
inferred← citeshttps://doi.org/10.1007/s00253-012-3958-7openalex-snapshot
Dengue virus-like particles: construction and application
inferred← citeshttps://doi.org/10.1007/s00253-015-6819-3openalex-snapshot
Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection
inferred← citeshttps://doi.org/10.1007/s00253-023-12817-5openalex-snapshot
Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain
inferred← citeshttps://doi.org/10.1007/s00299-015-1753-5openalex-snapshot
Antigen production using heterologous expression of dengue virus-2 non-structural protein 1 (NS1) in Nicotiana tabacum (Havana) for immunodiagnostic purposes
inferred← citeshttps://doi.org/10.1007/s00430-014-0334-5openalex-snapshot
Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice
inferred← citeshttps://doi.org/10.1007/s00705-013-1663-1openalex-snapshot
Rotavirus infection and its genetic characterization in non-hospitalized adults with acute gastroenteritis in Shanghai, China
inferred← citeshttps://doi.org/10.1007/s10096-011-1429-1openalex-snapshot
Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia
inferred← citeshttps://doi.org/10.1007/s10096-015-2540-5openalex-snapshot
Epidemiology and characteristics of the dengue outbreak in Guangdong, Southern China, in 2014
inferred← citeshttps://doi.org/10.1007/s10529-017-2462-7openalex-snapshot
Development of RNA aptamer that inhibits methyltransferase activity of dengue virus
inferred← citeshttps://doi.org/10.1007/s10708-024-11073-yopenalex-snapshot
Dengue in the urban slums of Pakistan: health costs, adaptation practices, and the role of dengue-diagnosis and surveillance in controlling the epidemic
inferred← citeshttps://doi.org/10.1007/s11033-010-0488-1openalex-snapshot
A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies
inferred← citeshttps://doi.org/10.1007/s11033-022-07957-2openalex-snapshot
Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2
inferred← citeshttps://doi.org/10.1007/s11103-011-9766-0openalex-snapshot
Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts
inferred← citeshttps://doi.org/10.1007/s11262-009-0418-2openalex-snapshot
Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties
inferred← citeshttps://doi.org/10.1007/s11274-021-03097-0openalex-snapshot
Aptamers isolated against mosquito-borne pathogens
inferred← citeshttps://doi.org/10.1007/s11515-008-0015-8openalex-snapshot
Study on immunity of dengue virus and dengue vaccine development
inferred← citeshttps://doi.org/10.1007/s11515-009-0015-8openalex-snapshot
Study on immunity of dengue virus and dengue vaccine development
inferred← citeshttps://doi.org/10.1007/s11538-019-00681-2openalex-snapshot
Coinfection, Altered Vector Infectivity, and Antibody-Dependent Enhancement: The Dengue–Zika Interplay
inferred← citeshttps://doi.org/10.1007/s11626-009-9218-1openalex-snapshot
Establishment and characterization of a new Aedes aegypti (L.) (Diptera: Culicidae) cell line with special emphasis on virus susceptibility
inferred← citeshttps://doi.org/10.1007/s11816-018-0487-6openalex-snapshot
Enhanced expression of dengue virus EDIII-based tetravalent antigen protein using transgenic rice callus
inferred← citeshttps://doi.org/10.1007/s11908-010-0102-7openalex-snapshot
Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development
inferred← citeshttps://doi.org/10.1007/s12035-017-0442-5openalex-snapshot
Evaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System
inferred← citeshttps://doi.org/10.1007/s12052-011-0365-yopenalex-snapshot
The Double-Edged Sword: How Evolution Can Make or Break a Live-Attenuated Virus Vaccine
inferred← citeshttps://doi.org/10.1007/s12250-015-3624-1openalex-snapshot
Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past
inferred← citeshttps://doi.org/10.1007/s13337-019-00561-2openalex-snapshot
Finding small molecules with pan-serotype activity to target Dengue non-structural protein 1
inferred← citeshttps://doi.org/10.1007/s40011-011-0006-9openalex-snapshot
Dengue and Other Viral Hemorrhagic Fevers in India
inferred← citeshttps://doi.org/10.1007/s40506-014-0025-1openalex-snapshot
Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment
inferred← citeshttps://doi.org/10.1007/s40506-017-0132-xopenalex-snapshot
Moving to a Dengue Preventive Treatment Through New Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-12-374153-0.00016-3openalex-snapshot
Arbovirus Evolution
inferred← citeshttps://doi.org/10.1016/b978-0-12-384939-7.10007-9openalex-snapshot
Pathogenesis
inferred← citeshttps://doi.org/10.1016/b978-0-12-803252-7.00010-2openalex-snapshot
Aedes aegypti Immune Responses to Dengue Virus
inferred← citeshttps://doi.org/10.1016/b978-0-12-818270-3.00004-7openalex-snapshot
Global health-care perspective of Dengue viral disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-04404-2.10092-2openalex-snapshot
Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-04579-7.00127-1openalex-snapshot
Dengue
inferred← citeshttps://doi.org/10.1016/b978-0-443-19130-5.00025-3openalex-snapshot
Dengue fever and its neurological complications
inferred← citeshttps://doi.org/10.1016/b978-0-7020-3935-5.00075-6openalex-snapshot
Dengue and Dengue Hemorrhagic Fever
inferred← citeshttps://doi.org/10.1016/b978-0-7020-6285-8.00132-5openalex-snapshot
Viral Hemorrhagic Fevers
inferred← citeshttps://doi.org/10.1016/b978-0-7234-3691-1.00103-3openalex-snapshot
Vaccines
inferred← citeshttps://doi.org/10.1016/j.actbio.2018.08.011openalex-snapshot
Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2008.06.007openalex-snapshot
The flavivirus polymerase as a target for drug discovery
inferred← citeshttps://doi.org/10.1016/j.antiviral.2008.06.010openalex-snapshot
Mouse models of dengue virus infection and disease
inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.09.011openalex-snapshot
A small molecule fusion inhibitor of dengue virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.11.009openalex-snapshot
Structure and functionality in flavivirus NS-proteins: Perspectives for drug design
inferred← citeshttps://doi.org/10.1016/j.antiviral.2011.05.001openalex-snapshot
Development and characterization of a stable luciferase dengue virus for high-throughput screening
inferred← citeshttps://doi.org/10.1016/j.antiviral.2012.06.010openalex-snapshot
Resistance analysis of an antibody that selectively inhibits dengue virus serotype-1
inferred← citeshttps://doi.org/10.1016/j.antiviral.2013.01.011openalex-snapshot
3′,5′Di-O-trityluridine inhibits in vitro flavivirus replication
inferred← citeshttps://doi.org/10.1016/j.antiviral.2016.03.017openalex-snapshot
An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target
inferred← citeshttps://doi.org/10.1016/j.antiviral.2021.105193openalex-snapshot
ML-SA1 and SN-2 inhibit endocytosed viruses through regulating TRPML channel expression and activity
inferred← citeshttps://doi.org/10.1016/j.antiviral.2022.105423openalex-snapshot
Flavivirus NS4B protein: Structure, function, and antiviral discovery
inferred← citeshttps://doi.org/10.1016/j.apjtm.2016.03.004openalex-snapshot
Current perspectives on dengue episode in Malaysia
inferred← citeshttps://doi.org/10.1016/j.apjtm.2017.03.003openalex-snapshot
Towards development of a universal dengue vaccine – How close are we?
inferred← citeshttps://doi.org/10.1016/j.apm.2016.11.022openalex-snapshot
Understanding epidemics from mathematical models: Details of the 2010 dengue epidemic in Bello (Antioquia, Colombia)
inferred← citeshttps://doi.org/10.1016/j.biologicals.2018.10.003openalex-snapshot
Human single-chain variable fragment antibody expressed in E. coli with optimal in vitro cross-neutralizing and no enhancing activity
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112304openalex-snapshot
Targets and strategies for vaccine development against dengue viruses
inferred← citeshttps://doi.org/10.1016/j.bios.2014.10.060openalex-snapshot
Quantum dots and duplex-specific nuclease enabled ultrasensitive detection and serotyping of Dengue viruses in one step in a single tube
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2010.11.008openalex-snapshot
Review of dengue virus and the development of a vaccine
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.06.049openalex-snapshot
Discovery of novel dengue virus entry inhibitors via a structure-based approach
inferred← citeshttps://doi.org/10.1016/j.bpc.2021.106553openalex-snapshot
Dengue fusion peptide in Langmuir monolayers: A binding parameter study
inferred← citeshttps://doi.org/10.1016/j.cell.2021.11.009openalex-snapshot
Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics
inferred← citeshttps://doi.org/10.1016/j.chemolab.2016.04.006openalex-snapshot
Adefovir dipivoxil — A possible regimen for the treatment of dengue virus (DENV) infection
inferred← citeshttps://doi.org/10.1016/j.chom.2008.08.004openalex-snapshot
Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
inferred← citeshttps://doi.org/10.1016/j.chom.2008.11.004openalex-snapshot
Waste Not, Want Not: A Viral RNA Degradation Product Modulates West Nile Virus Pathogenesis
inferred← citeshttps://doi.org/10.1016/j.chom.2009.09.003openalex-snapshot
Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus
inferred← citeshttps://doi.org/10.1016/j.chom.2010.01.004openalex-snapshot
Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
inferred← citeshttps://doi.org/10.1016/j.chom.2010.08.007openalex-snapshot
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
inferred← citeshttps://doi.org/10.1016/j.chom.2010.10.007openalex-snapshot
Mouse STAT2 Restricts Early Dengue Virus Replication
inferred← citeshttps://doi.org/10.1016/j.chom.2016.05.004openalex-snapshot
An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors
inferred← citeshttps://doi.org/10.1016/j.cimid.2012.12.002openalex-snapshot
Experimental infection of Artibeus intermedius bats with serotype-2 dengue virus
inferred← citeshttps://doi.org/10.1016/j.cyto.2011.01.013openalex-snapshot
Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability
inferred← citeshttps://doi.org/10.1016/j.dci.2013.10.002openalex-snapshot
Aedes aegypti ML and Niemann-Pick type C family members are agonists of dengue virus infection
inferred← citeshttps://doi.org/10.1016/j.ejmech.2013.04.034openalex-snapshot
In search of flavivirus inhibitors: Evaluation of different tritylated nucleoside analogues
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111628openalex-snapshot
De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus
inferred← citeshttps://doi.org/10.1016/j.enzmictec.2012.05.005openalex-snapshot
Using recombinant DNA technology for the development of live-attenuated dengue vaccines
inferred← citeshttps://doi.org/10.1016/j.epidem.2024.100806openalex-snapshot
Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2012.05.028openalex-snapshot
Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides
inferred← citeshttps://doi.org/10.1016/j.ijid.2019.03.016openalex-snapshot
Dengue vaccine clinical trials in India — An opportunity to inform the global response to a re-emerging disease challenge
inferred← citeshttps://doi.org/10.1016/j.ijregi.2023.09.001openalex-snapshot
Clinical profile and early severity predictors of dengue fever: Current trends for the deadliest dengue infection in Bangladesh in 2022
inferred← citeshttps://doi.org/10.1016/j.imj.2021.12.003openalex-snapshot
Host immunity and vaccine development against Dengue virus
inferred← citeshttps://doi.org/10.1016/j.immuni.2010.10.008openalex-snapshot
From Vaccines to Memory and Back
inferred← citeshttps://doi.org/10.1016/j.imu.2016.06.001openalex-snapshot
Identification of bioflavonoid as fusion inhibitor of dengue virus using molecular docking approach
inferred← citeshttps://doi.org/10.1016/j.isci.2022.104034openalex-snapshot
Single-cell temporal analysis of natural dengue infection reveals skin-homing lymphocyte expansion one day before defervescence
inferred← citeshttps://doi.org/10.1016/j.jbiosc.2010.05.001openalex-snapshot
Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
inferred← citeshttps://doi.org/10.1016/j.jbiosc.2014.06.005openalex-snapshot
Expression and characterization of an M cell-specific ligand-fused dengue virus tetravalent epitope using Saccharomyces cerevisiae
inferred← citeshttps://doi.org/10.1016/j.jcv.2015.01.011openalex-snapshot
Molecular classification of outcomes from dengue virus -3 infections
inferred← citeshttps://doi.org/10.1016/j.jinf.2009.10.003openalex-snapshot
Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response
inferred← citeshttps://doi.org/10.1016/j.jip.2011.05.002openalex-snapshot
Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system
inferred← citeshttps://doi.org/10.1016/j.jiph.2013.07.008openalex-snapshot
Factors associated with dengue fever IgG sero-prevalence in South Kordofan State, Sudan, in 2012: Reporting prevalence ratios
inferred← citeshttps://doi.org/10.1016/j.jiph.2019.03.010openalex-snapshot
Emerging infectious disease prevention: Where should we invest our resources and efforts?
inferred← citeshttps://doi.org/10.1016/j.jiph.2021.03.014openalex-snapshot
Full-genome sequencing and analysis of DENV-3 serotype isolated from Yemen
inferred← citeshttps://doi.org/10.1016/j.jiph.2023.08.001openalex-snapshot
Dengue overview: An updated systemic review
inferred← citeshttps://doi.org/10.1016/j.jmii.2020.03.007openalex-snapshot
Dengue hemorrhagic fever – A systemic literature review of current perspectives on pathogenesis, prevention and control
inferred← citeshttps://doi.org/10.1016/j.jopr.2013.01.016openalex-snapshot
Active site specific pharmacophore-based screening for methyltransferase inhibitors
inferred← citeshttps://doi.org/10.1016/j.jtbi.2011.12.006openalex-snapshot
Constraints on the use of lifespan-shortening Wolbachia to control dengue fever
inferred← citeshttps://doi.org/10.1016/j.jtbi.2013.10.006openalex-snapshot
Country- and age-specific optimal allocation of dengue vaccines
inferred← citeshttps://doi.org/10.1016/j.jtbi.2018.03.024openalex-snapshot
Epidemicity thresholds for water-borne and water-related diseases
inferred← citeshttps://doi.org/10.1016/j.jtbi.2019.03.010openalex-snapshot
T-Cell mediated adaptive immunity and antibody-dependent enhancement in secondary dengue infection
inferred← citeshttps://doi.org/10.1016/j.jtbi.2019.110014openalex-snapshot
A vector-host model to assess the impact of superinfection exclusion on vaccination strategies using dengue and yellow fever as case studies
inferred← citeshttps://doi.org/10.1016/j.jvacx.2024.100604openalex-snapshot
Current status of the development of dengue vaccines
inferred← citeshttps://doi.org/10.1016/j.jviromet.2009.10.026openalex-snapshot
A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells
inferred← citeshttps://doi.org/10.1016/j.jviromet.2010.03.002openalex-snapshot
Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.mbs.2015.02.004openalex-snapshot
The role of antibody in enhancing dengue virus infection
inferred← citeshttps://doi.org/10.1016/j.meegid.2020.104680openalex-snapshot
Evolution and epidemiologic dynamics of dengue virus in Nicaragua during the emergence of chikungunya and Zika viruses
inferred← citeshttps://doi.org/10.1016/j.micinf.2012.05.002openalex-snapshot
Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice
inferred← citeshttps://doi.org/10.1016/j.micinf.2020.05.004openalex-snapshot
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
inferred← citeshttps://doi.org/10.1016/j.micpath.2020.104563openalex-snapshot
Antiviral activity of astragaloside II, astragaloside III and astragaloside IV compounds against dengue virus: Computational docking and in vitro studies
inferred← citeshttps://doi.org/10.1016/j.modpat.2023.100188openalex-snapshot
Flaviviruses and the Traveler: Around the World and to Your Stage. A Review of West Nile, Yellow Fever, Dengue, and Zika Viruses for the Practicing Pathologist
inferred← citeshttps://doi.org/10.1016/j.molimm.2012.11.007openalex-snapshot
Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice
inferred← citeshttps://doi.org/10.1016/j.pep.2013.01.009openalex-snapshot
Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae
inferred← citeshttps://doi.org/10.1016/j.preteyeres.2018.04.004openalex-snapshot
Zika and the Eye: Pieces of a Puzzle
inferred← citeshttps://doi.org/10.1016/j.sleep.2020.05.011openalex-snapshot
The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population
inferred← citeshttps://doi.org/10.1016/j.snb.2015.05.067openalex-snapshot
Electrochemical immunosensor for dengue virus serotypes based on 4-mercaptobenzoic acid modified gold nanoparticles on self-assembled cysteine monolayers
inferred← citeshttps://doi.org/10.1016/j.str.2012.01.014openalex-snapshot
Capturing a Virus while It Catches Its Breath
inferred← citeshttps://doi.org/10.1016/j.surneu.2009.01.021openalex-snapshot
Intracranial hemorrhage in dengue fever: management and outcome
inferred← citeshttps://doi.org/10.1016/j.tim.2010.04.003openalex-snapshot
Targeting a host process as an antiviral approach against dengue virus
inferred← citeshttps://doi.org/10.1016/j.tim.2016.09.003openalex-snapshot
A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza
inferred← citeshttps://doi.org/10.1016/j.trstmh.2010.06.003openalex-snapshot
A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam
inferred← citeshttps://doi.org/10.1016/j.vaccine.2007.11.082openalex-snapshot
Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
inferred← citeshttps://doi.org/10.1016/j.vaccine.2008.05.058openalex-snapshot
“Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
inferred← citeshttps://doi.org/10.1016/j.vaccine.2008.08.019openalex-snapshot
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
inferred← citeshttps://doi.org/10.1016/j.vaccine.2009.09.098openalex-snapshot
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.10.043openalex-snapshot
WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11–12 May 2009
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.03.002openalex-snapshot
Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.07.020openalex-snapshot
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.11.072openalex-snapshot
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.12.034openalex-snapshot
Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant
inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.06.036openalex-snapshot
Dengue dynamics and vaccine cost-effectiveness in Brazil
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.03.091openalex-snapshot
Highly efficient production of a dengue pseudoinfectious virus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.05.053openalex-snapshot
A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.07.008openalex-snapshot
Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.08.087openalex-snapshot
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.06.067openalex-snapshot
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.10.037openalex-snapshot
The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review
inferred← citeshttps://doi.org/10.1016/j.virol.2008.04.044openalex-snapshot
Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains
inferred← citeshttps://doi.org/10.1016/j.virol.2008.08.008openalex-snapshot
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
inferred← citeshttps://doi.org/10.1016/j.virol.2008.08.021openalex-snapshot
Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation
inferred← citeshttps://doi.org/10.1016/j.virol.2009.03.025openalex-snapshot
Cholesterol biosynthesis modulation regulates dengue viral replication
inferred← citeshttps://doi.org/10.1016/j.virol.2009.12.010openalex-snapshot
Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1
inferred← citeshttps://doi.org/10.1016/j.virol.2010.12.016openalex-snapshot
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
inferred← citeshttps://doi.org/10.1016/j.virol.2010.12.020openalex-snapshot
Antibody-mediated neutralization of flaviviruses: A reductionist view
inferred← citeshttps://doi.org/10.1016/j.virol.2012.03.007openalex-snapshot
Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric Yellow Fever 17D/Dengue viruses
inferred← citeshttps://doi.org/10.1016/j.virol.2015.10.006openalex-snapshot
Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model
inferred← citeshttps://doi.org/10.1016/j.virol.2017.04.031openalex-snapshot
Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.virs.2024.12.008openalex-snapshot
Zika virus infections and associated risk factors among pregnant women in Gombe, Nigeria
inferred← citeshttps://doi.org/10.1016/j.virusres.2010.07.014openalex-snapshot
Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis
inferred← citeshttps://doi.org/10.1016/j.virusres.2014.01.001openalex-snapshot
The dengue virus non-structural 1 protein: Risks and benefits
inferred← citeshttps://doi.org/10.1016/j.virusres.2016.07.001openalex-snapshot
Early dengue virus interactions: the role of dendritic cells during infection
inferred← citeshttps://doi.org/10.1016/j.virusres.2016.12.003openalex-snapshot
Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection
inferred← citeshttps://doi.org/10.1016/j.virusres.2017.06.015openalex-snapshot
Complete genome analysis of dengue virus type 3 isolated from the 2013 dengue outbreak in Yunnan, China
inferred← citeshttps://doi.org/10.1016/j.xphs.2024.05.010openalex-snapshot
Next-generation Dengue Vaccines: Leveraging Peptide-Based Immunogens and Advanced Nanoparticles as Delivery Platforms
inferred← citeshttps://doi.org/10.1016/s0140-6736(08)61069-7openalex-snapshot
Dengue fever: a call for local, national, and international action
inferred← citeshttps://doi.org/10.1016/s0929-6646(09)60379-xopenalex-snapshot
Transient Hemophagocytic Activity in Dengue Immunopathogenesis
inferred← citeshttps://doi.org/10.1016/s1386-6532(09)70285-9openalex-snapshot
Foreword
inferred← citeshttps://doi.org/10.1016/s1473-3099(12)70246-3openalex-snapshot
Lessons from malaria control to help meet the rising challenge of dengue
inferred← citeshttps://doi.org/10.1016/s1473-3099(14)70811-4openalex-snapshot
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
inferred← citeshttps://doi.org/10.1016/s1473-3099(16)00026-8openalex-snapshot
The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
inferred← citeshttps://doi.org/10.1016/s2222-1808(14)60681-2openalex-snapshot
Homology and conservation of amino acids in E-protein sequences of dengue serotypes
inferred← citeshttps://doi.org/10.1017/s0950268812000908openalex-snapshot
Molecular evolution and epidemiology of four serotypes of dengue virus in Thailand from 1973 to 2007
inferred← citeshttps://doi.org/10.1017/s1462399408000665openalex-snapshot
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.3c00249openalex-snapshot
Synthesis of Isolated DNA Aptamer and Its Application of AC-Electrothermal Flow-Based Rapid Biosensor for the Detection of Dengue Virus in a Spiked Sample
inferred← citeshttps://doi.org/10.1021/acsinfecdis.8b00054openalex-snapshot
Preclinical Antiviral Testing for Dengue Virus Infection in Mouse Models and Its Association with Clinical Studies
inferred← citeshttps://doi.org/10.1021/jacs.3c11760openalex-snapshot
Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition
inferred← citeshttps://doi.org/10.1021/jm300171vopenalex-snapshot
Design, Synthesis, and Biological Evaluation of N -Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of Dengue Virus Infection
inferred← citeshttps://doi.org/10.1021/jm900652eopenalex-snapshot
The Medicinal Chemistry of Dengue Fever
inferred← citeshttps://doi.org/10.1021/jm900776mopenalex-snapshot
Novel Inhibitors of Dengue Virus Methyltransferase: Discovery by in Vitro-Driven Virtual Screening on a Desktop Computer Grid
inferred← citeshttps://doi.org/10.1038/emi.2016.74openalex-snapshot
Vaccines and immunization strategies for dengue prevention
inferred← citeshttps://doi.org/10.1038/labinvest.2008.70openalex-snapshot
Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model
inferred← citeshttps://doi.org/10.1038/labinvest.2017.10openalex-snapshot
Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation
inferred← citeshttps://doi.org/10.1038/nature10355openalex-snapshot
The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations
inferred← citeshttps://doi.org/10.1038/nbt0508-525openalex-snapshot
Flavivirus DNA vaccine with a kick
showing the first 200 of 591 · page through all 591
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.